Sparsentan (SPAR) in Combination with a SGLT2 Inhibitor (SGLT2i) and Steroid as First-Line Treatment for IgA Nephropathy (IgAN): A Case Report

Authors: Ray Reza Goshtaseb, Agness Pelts Block, Christopher Gisler

Published: 2024-10-28

DOI: 10.1681/asn.2024bhs2q50t

Keywords: No keywords found.

Abstract:
No abstract found.

Source: